Our consultancy team can help you decide if an EAP is right for your asset, find the optimal timing, understand the regulatory structure, and integrate your EAP with RWD and commercialisation.
Our consultancy team brings together experience in pharmaceutical commercialization, international regulatory law, and pharmacy – domestically and internationally. We’ll work with you to develop the best solution for each potential therapy.
Physicians want to do the best for their patients and often ask for access to innovative new therapies.
Typically, our team works with functions across your pharma biotech company, providing insight into:
A legal adviser by training and leading regulatory and medical ethics expert within the UK and EU. He brings a rigorous legal and analytical mind to all the issues.
A 25-year veteran of the pharma industry who has worked in commercial and supply chain functions. He brings the knowledge of integration and hands on experience in international EAP.
A qualified pharmacist with a focus on international pharmacy, Kirti combines deep knowledge of practice and regulation with a patient-centric approach.
The team has worked on numerous consulting projects across regulatory jurisdictions, therapy areas, and innovative companies. They’re also supported by an expert team from across Smartway.